Financials
- Market Capitalization 3.87 B
- Employee 145
- Founded 2015
- CEO N/A
- Website www.ideayabio.com
- Headquarter Delaware, United States
- FIGI BBG00CTZ4D83
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1518 | TNGX Tango Therapeutics, Inc. - Common Stock | 23.34 USD | -7.67% | -1.10% | -13.01% | +253.10% | 3.94 B USD | ||
| 1532 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +71.22% | +277.61% | 3.87 B USD | ||
| 1541 | DNLI Denali Therapeutics Inc. - Common Stock | 24.00 USD | -2.72% | -3.54% | +5.03% | +48.42% | 3.84 B USD | ||
| 1544 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.29 USD | -0.79% | -1.48% | +10.69% | +78.92% | 3.82 B USD |
Frequently asked questions about IDEAYA Biosciences, Inc. Common Stock
What is the IDEAYA Biosciences, Inc. Common Stock stock price today?
The current price of IDEAYA Biosciences, Inc. Common Stock (IDYA) is 40.11. Over the past 24 hours, the stock has changed by -3.97%. Follow the IDYA chart for real-time price dynamics.
What is the stock ticker of IDEAYA Biosciences, Inc. Common Stock?
IDEAYA Biosciences, Inc. Common Stock trades under the ticker IDYA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is IDEAYA Biosciences, Inc. Common Stock stock going up?
IDYA has changed by +1.08% over the last week, +13.08% over the last month, and +23.11% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of IDEAYA Biosciences, Inc. Common Stock?
IDEAYA Biosciences, Inc. Common Stock currently has a market capitalization of 3.87 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were IDEAYA Biosciences, Inc. Common Stock earnings last quarter?
Last quarter, IDEAYA Biosciences, Inc. Common Stock reported earnings of -1.22 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was IDEAYA Biosciences, Inc. Common Stock revenue for the last quarter?
IDEAYA Biosciences, Inc. Common Stock reported quarterly revenue of 8.86 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was IDEAYA Biosciences, Inc. Common Stock net income for the last quarter?
IDEAYA Biosciences, Inc. Common Stock reported net income of -112.45 M for the last quarter. The previous quarter showed -98.54 M, which means net income changed by -14.12%.
How many employees does IDEAYA Biosciences, Inc. Common Stock have?
As of the latest available data, IDEAYA Biosciences, Inc. Common Stock has 145 employees. Workforce size can provide additional context about the company's scale and operations.
What is IDEAYA Biosciences, Inc. Common Stock EBITDA?
IDEAYA Biosciences, Inc. Common Stock EBITDA is -121.6 M, and its EBITDA margin is -1 372.96%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy IDEAYA Biosciences, Inc. Common Stock stock?
You can buy IDEAYA Biosciences, Inc. Common Stock (IDYA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in IDEAYA Biosciences, Inc. Common Stock stock?
Investing in IDEAYA Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IDYA chart and related analysis on metatrader.com as part of your research.